A carcinogen is a substance capable of causing cancer.
The first Zantac lawsuit was filed after a cancer-causing substance was found in the heartburn drug during lab testing. Zantac and its generic form, ranitidine, both tested positive for the impurity.
The FDA and drug manufacturers are investigating this problem. As officials learn about the link between Zantac and cancer, the number of Zantac lawsuits is expected to grow.Considering a Zantac lawsuit? Get a Free, No-Obligation Case Review Today
Why Are People Filing Zantac Lawsuits?
During routine tests, online pharmacy Valisure found probable human carcinogen N-nitrosodimethylamine (NDMA) in Zantac. NDMA was also found in the generic form of the drug, ranitidine.
NDMA was found at more than 3,000 times the limit set by the U.S. Food and Drug Administration (FDA). Manufacturers recalled all drugs with NDMA at levels above the acceptable daily limit.
The cancer risk for patients taking NDMA-contaminated Zantac has yet to be determined. However, patients have begun filing ranitidine lawsuits against Zantac’s current manufacturer, Sanofi. Lawsuits have also been filed against previous Zantac manufacturer, Boehringer Ingelheim.
The first class action lawsuit was filed shortly after the FDA’s first public statement about Zantac. The lawsuit named multiple Zantac drug manufacturers. Several other individual and class action lawsuits against ranitidine manufacturers have been filed so far.
Early Ranitidine Class Action Lawsuits
The first Zantac class action lawsuit was filed in the Northern District of California. Four plaintiffs filed a legal complaint against Sanofi and Boehringer Ingelheim. The plaintiffs claimed the two manufacturers failed to warn consumers of the established scientific link between ranitidine and NDMA. Plaintiffs say this omission misled and endangered patients.
The second class action lawsuit against ranitidine was filed on September 20, 2019. It was filed in the District of New Jersey. It lists similar allegations to the first complaint. Additional Zantac class action lawsuits have since been filed in New York and Connecticut.
A class action lawsuit groups together similar cases under one plaintiff or lead representative. This results in one legal proceeding for the group of lawsuits rather than one individual lawsuit per plaintiff.
Zantac Lawsuit FAQs
Who Is Eligible to File a Zantac Cancer Lawsuit?
If you or a loved one developed cancer while taking the heartburn drug Zantac or another drug containing ranitidine, you may be eligible to file a lawsuit against Zantac manufacturers.
You may have a viable case if you have been diagnosed with any of the following cancers:
- Stomach cancer
- Bladder cancer
- Small intestine cancer
- Colorectal cancer
- Esophageal cancer
- Kidney cancer
- Liver cancer
- Prostate cancer
- Pancreatic cancer
- Non-Hodgkin’s lymphoma
- Multiple myeloma
Learn more about your legal options today by submitting a free case review.
What Compensation Is Available for a Zantac Lawsuit?
No ranitidine lawsuits have been settled or gone to trial yet. So the range of compensation has yet to be determined for these specific cases. However, in similar litigation, plaintiffs tend to claim common legal damages:
- Legal damages may include the cost of additional medical treatments related to a cancer diagnosis.
- Legal damages may include loss of income due to the cancer diagnosis and treatments.
- Legal damages may include physical and emotional pain from cancer.
- Some ranitidine lawsuits may seek punitive damages to punish the manufacturer for negligence and wrongdoing.
Is There A Recall on Zantac (ranitidine)?
Yes — the FDA has recalled certain lots of Zantac and generic ranitidine medications. To learn more about the recall and medications affected, visit our Zantac recall page.Free Zantac Case Review
Connect with our legal experts today.